I don’t see how this necessarily precludes IDC reimbursement.

The prior sentence states: “Cost-sharing arrangements for mobility assignments are negotiated between the participating organizations. The Federal agency may agree to pay all, some, or none of the costs associated with an assignment.”

While the next sentence states: “Costs may include basic pay, supplemental pay, fringe benefits, and travel and relocation expenses,” it’s not saying “may only.”

There is not explicit statement that says “F&A will not be paid”.

Mike

Michael Joseph Kusiak

Research Policy Analyst

University of California, Office of the President

Email: xxxxxx@ucop.edu

Phone: 510-987-0659

From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of McKeough, Pamela Marie
Sent: Thursday, February 23, 2012 12:07 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Intergovernmental Personnel Act (IPA) Agreement

F&A is not paid. See http://www.opm.gov/programs/ipa/Mobility.asp

Excerpt: Costs may include basic pay, supplemental pay, fringe benefits, and travel and relocation expenses.

Pam McKeough

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Pamela M. McKeough, CRA
Director, Research Data and Analysis

Office of Research Administration
Indiana University

From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of Anthony Ventimiglia
Sent: Tuesday, February 21, 2012 2:46 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Intergovernmental Personnel Act (IPA) Agreement

Good afternoon all,

I wanted to query the listserv to see if any institutions have budgeted/received indirect costs on IPA Agreements. Any comments/thoughts are greatly appreciated!

Thanks,

Tony

Tony Ventimiglia
Associate Director
Education & Communication
Office of Sponsored Programs
310 Samford Hall
Auburn University, Alabama 36849
334-844-5954 (p)
334-844-5953 (f)
xxxxxx@auburn.edu

"The information transmitted in this message and attachments, if any, is intended only for the person or entity to which it is addressed and may contain information that is privileged, confidential, and exempt from disclosure under applicable law.

Any review, transmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and delete the material from your computer."

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help ======================================================================